申请人:PLIVA and PLIVA Handels GmbH
公开号:US05466686A1
公开(公告)日:1995-11-14
The invention relates to the novel 4-oxo-azetidine-2-sulfonic acid amides and their salts of the formula I ##STR1## wherein the radicals have the meanings: R.sup.1 =hydrogen, halogen; R.sup.2 =hydrogen, halogen, NH.sub.2, C.sub.6 H.sub.5 CH.sub.2 CONH, C.sub.6 H.sub.5 OCH.sub.2 CONH, phthalimido, o-MeNHCOC.sub.6 H.sub.4 CONH, isoxazolylcarbonylamino; R.sup.3 =hydrogen, Me.sub.2 C.dbd.C--COOMe, H.sub.2 C.dbd.C(Me)--CH--COOMe, Me.sub.2 C.dbd.C--COOCH.sub.2 C.sub.6 H.sub.5, H.sub.2 C.dbd.C(Me)CH--COOCH.sub.2 C.sub.6 H.sub.4 NO.sub.2 -p, Me.sub.2 C.dbd.C--COOCH.sub.2 C.sub.6 H.sub.4 NO.sub.2 -p, Me.sub.2 C.dbd.C--COOCH.sub.2 C.sub.6 H.sub.4 Me-m, H.sub.2 C.dbd.C(Me)--CH--COOCH.sub.2 C.sub.6 H.sub.4 Me-m, Me.sub.2 C.dbd.C--COOH; R.sup.4 =hydrogen or sodium and R.sup.5 =hydrogen, alkyl, benzyl or heterocycle, i.e. isoxazole or pyrazole etc. The invention also relates to the procedure for the preparation thereof and the use thereof as intermediates in the synthesis of beta-lactam analogs or as active components for the preparations of the drugs for antimicrobial therapy.
本发明涉及新型的4-
氧代-
氮杂
环丁烷-2-
磺酸酰胺及其盐,其
化学式为I:##
STR1## 其中基团的含义为:R1=
氢、卤素;R2=
氢、卤素、NH2、C6H5CH2CONH、C6H5OCH2CONH、邻
苯二甲
酰亚胺、o-MeNHCOC6H4CONH、
异噁唑基甲
酰胺基;R3=
氢、Me2C=CH-COOMe、H2C=C(Me)-CH-COOMe、Me2C=CH-COOCH2C6H5、H2C=C(Me)CH-COOCH2C6H4NO2-p、Me2C=CH-COOCH2C6H4NO2-p、Me2C=CH-COOCH2C6H4Me-m、H2C=C(Me)-CH-COOCH2C6H4Me-m、Me2C=CH-COOH;R4=
氢或
钠;R5=
氢、烷基、
苯甲基或杂环,即
异噁唑或
吡唑等。本发明还涉及其制备方法以及用作β-内
酰胺类似物的合成
中间体或用于制备抗微
生物治疗药物的活性成分。